Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Global Market Report 2025

The enzyme-linked immunosorbent assay (ELISA) analyzers market size has grown strongly in recent years. It will grow from $0.71 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to the growing demand for high-throughput screening in drug discovery, an expanding elderly population with greater vulnerability to diseases, increased use of point-of-care diagnostics, rising global healthcare spending, and the heightened need for reliable and consistent diagnostic instruments.

The enzyme-linked immunosorbent assay (ELISA) analyzers market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The expected growth in the forecast period is driven by rising demand for personalized medicine, an increased emphasis on precision diagnostics, growing investments in healthcare research and development, expanding collaborations between research institutions and diagnostic companies, and greater adoption of miniaturized and portable diagnostic devices. Key trends during this period include enhanced multiplexing capabilities, advanced AI integration for data analysis, innovations in portable and handheld ELISA analyzers, combining ELISA with microfluidics for quicker results, and progress in automation and robotics for high-throughput screening.

The increasing prevalence of infectious diseases is expected to drive the growth of the enzyme-linked immunosorbent assay (ELISA) analyzers market in the coming years. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, and can spread directly or indirectly between people. The rise in infectious diseases is largely due to increased human interaction with the environment and greater global connectivity. ELISA analyzers aid in detecting infectious diseases by identifying specific antibodies or antigens in blood samples, enabling quick and accurate diagnosis that supports monitoring and managing disease outbreaks. For example, in March 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that approximately 10.8 million people contracted Tuberculosis (TB), a common bacterial infection, worldwide in 2023, including 6 million men, 3.6 million women, and 1.3 million children. Therefore, the growing prevalence of infectious diseases is fueling the expansion of the ELISA analyzers market.

Key players in the ELISA analyzers market are focusing on developing advanced products such as multi-mode microplate readers to boost efficiency in diagnostic and research applications. Multi-mode microplate readers are versatile devices that combine multiple detection technologies in one platform. They support a variety of assays, including ELISA and nucleic acid quantification, enhancing laboratory accuracy, throughput, and efficiency. For instance, in April 2022, Molecular Devices, LLC, a US-based provider of high-performance life science solutions, launched SpectraMax, a compact and cost-effective instrument designed for academic and biotech laboratories. This upgradeable reader supports up to three detection modes - UV-visible absorbance, fluorescence, and luminescence - and accommodates different plate formats (6- to 384-well). It features an extended fluorescence wavelength range (250 to 850 nm) using a xenon flash lamp and offers user-friendly plug-and-play filter cubes. The device integrates with SoftMax Pro Software for streamlined protocol management and data analysis, making it a flexible, space-saving tool for research labs.

In April 2023, DYNEX Technologies Inc., a US-based supplier of automated ELISA systems, partnered with Tecan Group Ltd. to improve the availability of ELISA immunoassay solutions in US laboratories. This collaboration aims to expand access to high-quality ELISA products in the U.S. market by integrating Tecan’s specialized kits with DYNEX’s automated platforms. Tecan Group Ltd. is a Switzerland-based company that provides benchtop microplate readers.

Major players in the enzyme-linked immunosorbent assay (elisa) analyzers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BioMerieux, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., EUROIMMUN Medizinische Labordiagnostika AG, Molecular Devices LLC, Quanterix, Berthold Technologies GmbH and Co. KG, Trinity Biotech Public Limited Company, Erba Mannheim GmbH, Dynex Technologies Inc., BMG Labtech GmbH, Awareness Technology Inc., Medicon Hellas S.A., Adaltis S.r.l., Gold Standard Diagnostics Corp.

North America was the largest region in the enzyme-linked immunosorbent assay (ELISA) analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enzyme-linked immunosorbent assay (ELISA) analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enzyme-linked immunosorbent assay (ELISA) analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Enzyme-linked immunosorbent assay (ELISA) analyzers are automated laboratory instruments designed to detect and quantify biological substances in different sample types. They work by using antibodies and antigens that bind together, along with enzyme-linked reagents that produce visible signals - often color changes - that indicate the amount of the target analyte present. These analyzers enhance diagnostic accuracy, consistency, and speed in clinical laboratories, while reducing human error and boosting overall lab efficiency.

The main types of enzyme-linked immunosorbent assay (ELISA) analyzers include benchtop ELISA analyzers, portable ELISA analyzers, automated ELISA workstations, and microplate readers. Benchtop ELISA analyzers are fixed lab instruments intended for high-volume, accurate detection of biomolecules such as proteins, antibodies, and antigens in both clinical and research environments. They employ various technologies, including colorimetric, fluorescence, chemiluminescence, and electrochemical ELISA methods, and serve multiple applications like vaccine development, immunology, diagnostics, toxicology, drug monitoring, and pharmaceutical manufacturing. These devices are utilized by a variety of end-users including diagnostic laboratories, research centers, pharmaceutical companies, the food and beverage industry, and academic institutions.

The enzyme-linked immunosorbent assay (ELISA) analyzers market research report is one of a series of new reports that provides enzyme-linked immunosorbent assay (ELISA) analyzers market statistics, including the enzyme-linked immunosorbent assay (ELISA) analyzers industry global market size, regional shares, competitors with the enzyme-linked immunosorbent assay (ELISA) analyzers market share, detailed enzyme-linked immunosorbent assay (ELISA) analyzers market segments, market trends, opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay (ELISA) analyzers industry. This enzyme-linked immunosorbent assay (ELISA) analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzyme-linked immunosorbent assay (ELISA) analyzers market consists of revenues earned by entities by providing services such as installation and calibration of analyzers, maintenance and technical support, training for laboratory personnel, software integration and upgrades, and validation and quality assurance services. The market value includes the value of related goods sold by the service provider or included within the service offering. enzyme-linked immunosorbent assay (ELISA) analyzers market also includes sales of ELISA plate washers, ELISA incubators, ELISA reagent dispensers, ELISA control and calibration systems, and hybrid ELISA platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.